Tissue substance P levels were altered in carpal tunnel syndrome patients, with changes correlating with nerve compression severity — suggesting this neuropeptide as a biomarker and potential therapeutic target.
Key findingTissue substance P levels were altered in carpal tunnel syndrome patients, with changes correlating with nerve compression severity — suggesting this
What the researchers found
Tissue substance P levels were altered in carpal tunnel syndrome patients, with changes correlating with nerve compression severity — suggesting this neuropeptide as a biomarker and potential therapeutic target.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Changes in tissue substance P levels in patients with carpal tunnel syndrome.
Neurosurgery, 67(6), 1655-60; discussion 1660-1
Citation
Öztürk, Niyazi; Erin, Nuray; Tüzüner, Serdar. (2010). Changes in tissue substance P levels in patients with carpal tunnel syndrome.. Neurosurgery, 67(6), 1655-60; discussion 1660-1. https://doi.org/10.1227/NEU.0b013e3181fa7032